Phentermine – appetite suppressant. Deksaflenflyurimin sold under the brand Reduks. It increases the level of seratonina in the brain. Seratonin – that substance, which is responsible for the transmission of nerve impulses. Connected with him improving mood and appearance of appetite. This drug was removed from public sale, so the reviews of it are only negative:
As with any substance that suppresses appetite, a hairdryer, hair dryers have a number of serious side effects, such as high blood pressure in the lungs, pulmonary stress and damage heart valves. Its action is aimed at the rapid weight loss and has nothing to do with a healthy balanced diet and physical exercise. From the open sale of phentermine without prescription was seized by the Office for Supervision of food and medicines.
Here’s the text of regulations of the Office for Supervision of Food and Drug Administration:
“Office for Supervision of Food and Drug Administration withdraws from public sale and flenflyuramin deksfenflyuramin
Office for the Supervision of the Food and Drug Administration based on new evidence of serious side effects associated with the effect of phentermine and deksfenflyuramina, asked manufacturers to voluntarily remove from the public sale of two medicines from obesity. Deksfenflyuramin made for the company and produced Interneron Pharmaceuticals Wyeth-Ayerst Laboratory, a subsidiary of American Home Products Corp. Madison called Reduks. Phentermine is ilaos sold without prescription. The company also manufactures and markets phentermine under the name Pondimin. Both companies agreed to voluntarily remove their products from the market. Office for the Supervision of the Food and Drug Administration does not require the withdrawal of phentermine, another well-known cure for obesity.
This ruling is due to the receipt of new data from physicians, assess the condition of patients taking these two drugs with echocardiograms, a special procedure that helps you test the heart valve. These studies showed that approximately 30% of patients screened, the results of echocardiograms showed abnormalities, although no symptoms of heart valve they had not. The resulting figure is several times higher than expected percentage of such pathologies. ”
“These results require us to immediate and decisive action – said Michael A. Friedman, MD, commissioner of the Office for Supervision of food and medicines. – Our data indicate that fenfluramine, and close to it in chemical composition deksfenflyuramin pose a serious threat to the health of patients who take them. ”
Office for the Supervision of the Food and Drug Administration recommends that patients using either of these products, discontinue their use. Those who make them, you should immediately contact their treating physicians to discuss further treatment regimen.
According to new data, phentermine and deksfenflyuramin may cause heart valve disease, similar to those due to which the Office has already twice publish a warning on the “fen-dryer, a mixture of fenfluramine and phentermine. “Fen-fen” in recent times has been widely used for long-term treatments of obesity.
In July, researchers from the Mayo Clinic and Mayo Foundation reported 24 cases of a rare breach of the heart valves in women who have undergone treatment “fen-hair-dryer. The Office has warned doctors that they had been received nine such reports, and appealed to all professionals in the field of medicine with a request to report all such cases in the department of medical supervision of the Office (1-800-FDA-1088/fax 1-800-FDA-0178 ) or to the relevant pharmaceutical manufacturers.
As a result, the Office has received 66 such reports of the defeat of a heart valve with a high degree of probability associated with the admission “fen-dryer. There were also reports of cases of disease in patients taking phentermine or clean deksfenflyuramin. Management has demanded that the producers placed a strong emphasis on the labels of these drugs and the instructions for use of the potential risk of cardiac disorders as a result of taking the medicine. The Office continues to receive reports of cardiac valve in patients taking these drugs.